These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

404 related items for PubMed ID: 34734314

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Emotional breakthrough and psychedelics: Validation of the Emotional Breakthrough Inventory.
    Roseman L, Haijen E, Idialu-Ikato K, Kaelen M, Watts R, Carhart-Harris R.
    J Psychopharmacol; 2019 Sep; 33(9):1076-1087. PubMed ID: 31294673
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. THC-O-Acetate: Scarce Evidence for a Psychedelic Cannabinoid.
    Kruger DJ, Bone CC, Meacham MC, Klein C, Kruger JS.
    J Psychoactive Drugs; 2024 Sep; 56(4):563-567. PubMed ID: 37381980
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Altered states of consciousness in Danish healthy volunteers and recreational users of psilocybin and the possible impact of setting and intention: Danish validation of the five-dimensional altered states of consciousness questionnaire.
    Hovmand OR, Madsen MK, Fisher PM, Stenbæk DS.
    J Psychopharmacol; 2024 Oct; 38(10):924-932. PubMed ID: 39135498
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Antidepressant effects of a psychedelic experience in a large prospective naturalistic sample.
    Nygart VA, Pommerencke LM, Haijen E, Kettner H, Kaelen M, Mortensen EL, Nutt DJ, Carhart-Harris RL, Erritzoe D.
    J Psychopharmacol; 2022 Aug; 36(8):932-942. PubMed ID: 35924888
    [Abstract] [Full Text] [Related]

  • 15. Illicit use of LSD or psilocybin, but not MDMA or nonpsychedelic drugs, is associated with mystical experiences in a dose-dependent manner.
    Lyvers M, Meester M.
    J Psychoactive Drugs; 2012 Aug; 44(5):410-7. PubMed ID: 23457892
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Significant Psychedelic Experiences Evaluated for Mystical Characteristics Associated with Cannabis Use Reduction and Psychological Flexibility Improvement: A Naturalistic Cross-Sectional Retrospective Survey.
    Romeo B, Kervadec E, Fauvel B, Strika-Bruneau L, Amirouche A, Verroust V, Piolino P, Benyamina A.
    J Psychoactive Drugs; 2024 Jul 03; ():1-12. PubMed ID: 38961652
    [Abstract] [Full Text] [Related]

  • 18. Classic psychedelics: An integrative review of epidemiology, therapeutics, mystical experience, and brain network function.
    Johnson MW, Hendricks PS, Barrett FS, Griffiths RR.
    Pharmacol Ther; 2019 May 03; 197():83-102. PubMed ID: 30521880
    [Abstract] [Full Text] [Related]

  • 19. Naturalistic use of psychedelics is related to emotional reactivity and self-consciousness: The mediating role of ego-dissolution and mystical experiences.
    Orłowski P, Ruban A, Szczypiński J, Hobot J, Bielecki M, Bola M.
    J Psychopharmacol; 2022 Aug 03; 36(8):987-1000. PubMed ID: 35475373
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 21.